PRMT1 Driven PTX3 Regulates Ferritinophagy in Glioma

Overview

Journal Autophagy

Specialty Cell Biology

Date 2023 Jan 17

PMID 36647288

Authors

Kirti Lathoria

Pruthvi Gowda

Sonia B Umdor

Shruti Patrick

Vaishali Suri

Ellora Sen

Affiliations

Soon will be listed here.

Abstract

Mutations in the Krebs cycle enzyme IDH1 (isocitrate dehydrogenase (NADP(+)) 1) are associated with better prognosis in gliomas. Though IDH1 mutant (IDH1) tumors are characterized by their antiproliferative signatures maintained through hypermethylation of DNA and chromatin, mechanisms affecting cell death pathways in these tumors are not well elucidated. On investigating the crosstalk between the IDH1 mutant epigenome, ferritinophagy and inflammation, diminished expression of PRMT1 (protein arginine methyltransferase 1) and its associated asymmetric dimethyl epigenetic mark H4R3me2a was observed in IDH1 gliomas. Reduced expression of PRMT1 was concurrent with diminished levels of PTX3, a key secretory factor involved in cancer-related inflammation. Lack of PRMT1 H4R3me2a in IDH1 mutant glioma failed to epigenetically activate the expression of with a reduction in YY1 (YY1 transcription factor) binding on its promoter. Transcriptional activation and subsequent secretion of PTX3 from cells was required for maintaining macroautophagic/autophagic balance as pharmacological or genetic ablation of PTX3 secretion in wild-type IDH1 significantly increased autophagic flux. Additionally, PTX3-deficient IDH1 mutant gliomas exhibited heightened autophagic signatures. Furthermore, we demonstrate that the PRMT1-PTX3 axis is important in regulating the levels of ferritin genes/iron storage and inhibition of this axis triggered ferritinophagic flux. This study highlights the conserved role of IDH1 mutants in augmenting ferritinophagic flux in gliomas irrespective of genetic landscape through inhibition of the PRMT1-PTX3 axis. This is the first study describing ferritinophagy in IDH1 mutant gliomas with mechanistic details. Of clinical importance, our study suggests that the PRMT1-PTX3 ferritinophagy regulatory circuit could be exploited for therapeutic gains. 2-HG: D-2-hydroxyglutarate; BafA: bafilomycin A; ChIP: chromatin immunoprecipitation; FTH1: ferritin heavy chain 1; FTL: ferritin light chain; GBM: glioblastoma; HMOX1/HO-1: heme oxygenase 1; IHC: immunohistochemistry; IDH1: isocitrate dehydrogenase(NADP(+))1; MDC: monodansylcadaverine; NCOA4: nuclear receptor coactivator 4; NFE2L2/Nrf2: NFE2 like bZIP transcription factor 2; PTX3/TSG-14: pentraxin 3; PRMT: protein arginine methyltransferase; SLC40A1: solute carrier family 40 member 1; Tan IIA: tanshinone IIA; TCA: trichloroacetic acid; TEM: transmission electron microscopy; TNF: tumor necrosis factor.

Citing Articles

Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy.

Huang D, Rezaeian A, Wang J, Qi Y, Chen H, Inuzuka H J Cancer Biol. 2025; 5(2):44-60.

PMID: 40018367 PMC: 11867627. DOI: 10.46439/cancerbiology.5.064.

NMF typing and machine learning algorithm-based exploration of preeclampsia-related mechanisms on ferroptosis signature genes.

Liu X, Zhang D, Qiu H Cell Biol Toxicol. 2024; 41(1):14.

PMID: 39707003 PMC: 11662041. DOI: 10.1007/s10565-024-09963-5.

Single-cell sequencing reveals PTX3 involvement in ovarian cancer metastasis.

Liu S, Wu T, Song X, Quan L, Wang X, Liu Q J Ovarian Res. 2024; 17(1):235.

PMID: 39580424 PMC: 11585133. DOI: 10.1186/s13048-024-01558-2.

PRMT1 promotes radiotherapy resistance in glioma stem cells by inhibiting ferroptosis.

Li H, Qi X, He L, Yang H, Ju H Jpn J Radiol. 2024; 43(1):129-137.

PMID: 39254902 DOI: 10.1007/s11604-024-01651-y.

Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma.

Ma M, Fei X, Jiang D, Chen H, Xie X, Wang Z Oncol Rev. 2024; 18:1432131.

PMID: 39193375 PMC: 11348391. DOI: 10.3389/or.2024.1432131.

References

Weintraub A, Li C, Zamudio A, Sigova A, Hannett N, Day D . YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017; 171(7):1573-1588.e28. PMC: 5785279. DOI: 10.1016/j.cell.2017.11.008. View

Guan Z, Chen J, Li X, Dong N . Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep. 2020; 40(8). PMC: 7953492. DOI: 10.1042/BSR20201807. View

Huang B, Ray P, Iwasaki K, Tsuji Y . Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4. FASEB J. 2013; 27(9):3763-74. PMC: 3752545. DOI: 10.1096/fj.12-226043. View

Gilbert M, Liu Y, Neltner J, Pu H, Morris A, Sunkara M . Autophagy and oxidative stress in gliomas with IDH1 mutations. Acta Neuropathol. 2013; 127(2):221-33. PMC: 3946987. DOI: 10.1007/s00401-013-1194-6. View

Budczies J, Klauschen F, Sinn B, Gyorffy B, Schmitt W, Darb-Esfahani S . Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS One. 2012; 7(12):e51862. PMC: 3522617. DOI: 10.1371/journal.pone.0051862. View

Sheikh T, Sen E . p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition. Cytokine. 2021; 140:155418. DOI: 10.1016/j.cyto.2020.155418. View

Aoki H, Kondo Y, Aldape K, Yamamoto A, Iwado E, Yokoyama T . Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy. 2008; 4(4):467-75. DOI: 10.4161/auto.5668. View

Pankiv S, Clausen T, Lamark T, Brech A, Bruun J, Outzen H . p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007; 282(33):24131-45. DOI: 10.1074/jbc.M702824200. View

Favia A, Salvatori L, Nanni S, Iwamoto-Stohl L, Valente S, Mai A . The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells. Sci Rep. 2019; 9(1):15925. PMC: 6828805. DOI: 10.1038/s41598-019-52291-6. View

10.

Dong F, Li Q, Yang C, Huo D, Wang X, Ai C . PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma. Nat Commun. 2018; 9(1):4552. PMC: 6208368. DOI: 10.1038/s41467-018-06968-7. View

11.

Ghosh S, Paul A, Sen E . Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling. Mol Cell Biol. 2013; 33(14):2718-31. PMC: 3700138. DOI: 10.1128/MCB.01254-12. View

12.

Santana-Codina N, Gikandi A, Mancias J . The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis. Adv Exp Med Biol. 2021; 1301:41-57. DOI: 10.1007/978-3-030-62026-4_4. View

13.

Thomas C, Henry W, Cuiffo B, Collmann A, Marangoni E, Benhamo V . Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Sci Signal. 2017; 10(467). PMC: 5858194. DOI: 10.1126/scisignal.aah4674. View

14.

Phillips R, Soshnev A, Allis C . Epigenomic Reprogramming as a Driver of Malignant Glioma. Cancer Cell. 2020; 38(5):647-660. PMC: 8248764. DOI: 10.1016/j.ccell.2020.08.008. View

15.

Giuliani V, Miller M, Liu C, Hartono S, Class C, Bristow C . PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun. 2021; 12(1):4626. PMC: 8324870. DOI: 10.1038/s41467-021-24798-y. View

16.

Guccione E, Richard S . The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019; 20(10):642-657. DOI: 10.1038/s41580-019-0155-x. View

17.

Shchors K, Massaras A, Hanahan D . Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit. Cancer Cell. 2015; 28(4):456-471. DOI: 10.1016/j.ccell.2015.08.012. View

18.

Choi S, Jeong H, Kim H, Choi D, Cho S, Seong J . Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis. Autophagy. 2019; 15(6):1069-1081. PMC: 6526864. DOI: 10.1080/15548627.2019.1569931. View

19.

Stallone G, Cormio L, Netti G, Infante B, Selvaggio O, Di Fino G . Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer. Cancer Res. 2014; 74(16):4230-8. DOI: 10.1158/0008-5472.CAN-14-0369. View

20.

Noushmehr H, Weisenberger D, Diefes K, Phillips H, Pujara K, Berman B . Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 2010; 17(5):510-22. PMC: 2872684. DOI: 10.1016/j.ccr.2010.03.017. View